Cargando…
Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
INTRODUCTION: The ever-increasing global hepatitis C infection is fueling the burden of diabetes mellitus, which exaggerates various complications and may be a cause of death for millions. Several studies have reported that hepatitis C virus infection is an important risk factor for the development...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388482/ https://www.ncbi.nlm.nih.gov/pubmed/30803444 http://dx.doi.org/10.1186/s13643-019-0976-x |
_version_ | 1783397773327990784 |
---|---|
author | Ambachew, Sintayehu Eshetie, Setegn Geremew, Demeke Endalamaw, Aklilu Melku, Mulugeta |
author_facet | Ambachew, Sintayehu Eshetie, Setegn Geremew, Demeke Endalamaw, Aklilu Melku, Mulugeta |
author_sort | Ambachew, Sintayehu |
collection | PubMed |
description | INTRODUCTION: The ever-increasing global hepatitis C infection is fueling the burden of diabetes mellitus, which exaggerates various complications and may be a cause of death for millions. Several studies have reported that hepatitis C virus infection is an important risk factor for the development of diabetes mellitus. However, the results of fragmented studies reported variable and inconsistent findings on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Therefore, this protocol for meta-analysis will determine the overall pooled prevalence of type 2 diabetes mellitus in patients infected with hepatitis C virus. METHODS AND ANALYSIS: This systematic review and meta-analysis will include original articles of cohort and cross-sectional studies published in English. A systematic search will be performed in PubMed, Science Direct, Scopus, and Google Scholar. A fixed/random-effects meta-analysis model will be used to estimate the global pooled prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Sensitivity analysis will be conducted to check the stability of the summary estimate. Heterogeneity will be assessed using the I(2) statistic. Subgroup analysis will also be conducted based on geographical region. Funnel plots and Egger’s test and Begg’s test will be used to assess for publication bias. ETHICS AND DISSEMINATION: The review is based on published data; therefore, ethical approval is not required. The systematic review and meta-analysis will summarize the existing data on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients at the global level. This provides the empirical evidence necessary for researchers, policymakers, and public health stakeholders to derive health-promoting policies, allocate resources, and set priorities for monitoring future trends. The final result will be presented at annual scientific meetings, conferences, and seminars. Moreover, it will also be published in a peer-reviewed reputable journal. We also plan to review every 5 years to provide updated information. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018083409 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13643-019-0976-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6388482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63884822019-03-19 Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis Ambachew, Sintayehu Eshetie, Setegn Geremew, Demeke Endalamaw, Aklilu Melku, Mulugeta Syst Rev Protocol INTRODUCTION: The ever-increasing global hepatitis C infection is fueling the burden of diabetes mellitus, which exaggerates various complications and may be a cause of death for millions. Several studies have reported that hepatitis C virus infection is an important risk factor for the development of diabetes mellitus. However, the results of fragmented studies reported variable and inconsistent findings on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Therefore, this protocol for meta-analysis will determine the overall pooled prevalence of type 2 diabetes mellitus in patients infected with hepatitis C virus. METHODS AND ANALYSIS: This systematic review and meta-analysis will include original articles of cohort and cross-sectional studies published in English. A systematic search will be performed in PubMed, Science Direct, Scopus, and Google Scholar. A fixed/random-effects meta-analysis model will be used to estimate the global pooled prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Sensitivity analysis will be conducted to check the stability of the summary estimate. Heterogeneity will be assessed using the I(2) statistic. Subgroup analysis will also be conducted based on geographical region. Funnel plots and Egger’s test and Begg’s test will be used to assess for publication bias. ETHICS AND DISSEMINATION: The review is based on published data; therefore, ethical approval is not required. The systematic review and meta-analysis will summarize the existing data on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients at the global level. This provides the empirical evidence necessary for researchers, policymakers, and public health stakeholders to derive health-promoting policies, allocate resources, and set priorities for monitoring future trends. The final result will be presented at annual scientific meetings, conferences, and seminars. Moreover, it will also be published in a peer-reviewed reputable journal. We also plan to review every 5 years to provide updated information. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018083409 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13643-019-0976-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-25 /pmc/articles/PMC6388482/ /pubmed/30803444 http://dx.doi.org/10.1186/s13643-019-0976-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Protocol Ambachew, Sintayehu Eshetie, Setegn Geremew, Demeke Endalamaw, Aklilu Melku, Mulugeta Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
title | Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
title_full | Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
title_fullStr | Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
title_full_unstemmed | Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
title_short | Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
title_sort | prevalence of type 2 diabetes mellitus among hepatitis c virus-infected patients: a protocol for systematic review and meta-analysis |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388482/ https://www.ncbi.nlm.nih.gov/pubmed/30803444 http://dx.doi.org/10.1186/s13643-019-0976-x |
work_keys_str_mv | AT ambachewsintayehu prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis AT eshetiesetegn prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis AT geremewdemeke prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis AT endalamawaklilu prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis AT melkumulugeta prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis |